MUHAMMAD ASHRAF ALIM MD NPI 1588619464

NPI Details

Muhammad Ashraf Alim, MD is a pulmonary disease internal medicine in Bakersfield, CA with 36 years of experience. The provider is an internist who treats diseases of the lungs and airways. The pulmonologist diagnoses and treats cancer, pneumonia, pleurisy, asthma, occupational and environmental diseases, bronchitis, sleep disorders, emphysema and other complex disorders of the lungs. Muhammad Ashraf Alim, MD NPI is 1588619464. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

3008 SILLECT AVE
SUITE 140
BAKERSFIELD, CA
ZIP 93308-340
Phone: (661) 377-0091
Fax: (661) 377-1715

The NPI 1588619464 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg (HCPCS:J7611)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Test for exercise-induced lung stress (HCPCS:94618)
• Inhalation treatment for airway obstruction or sputum production (HCPCS:94640)
• Test to measure expiratory airflow and volume changes before and after medication administration (HCPCS:94060)
• Test to measure largest amount of air breathed in an out (HCPCS:94200)
• Evaluation of use of breathing device (HCPCS:94664)
• Test to determine lung volumes using sensors (HCPCS:94726)
• Test to examine how well the lungs exchange gases (HCPCS:94729)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Annual depression screening, 15 minutes (HCPCS:G0444)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Sleep study in sleep lab (6 years or older) (HCPCS:95810)
• Sleep study in sleep lab with continuous airway pressure (6 years or older) (HCPCS:95811)
• Sleep study including heart rate, breathing, airflow, and effort (HCPCS:95806)
• Ct scan of chest without contrast (HCPCS:71250)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine, quadrivalent derived from cell cultures (HCPCS:90756)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free (HCPCS:90674)
• X-ray of chest, 2 views (HCPCS:71046)
• Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme (HCPCS:J7620)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 5/23/2006 and was last updated on 12/8/2016.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.